Naoto Kusunose

Title: Naoto Kusunose: Innovator in Cancer Immunology

Introduction

Naoto Kusunose is a prominent inventor based in Aioi, Japan. He has made significant contributions to the field of cancer immunology through his innovative research and patented inventions. His work focuses on developing novel peptides that can be utilized in cancer vaccines.

Latest Patents

Kusunose holds a patent for WT1 substitution peptides. This patent describes a novel substituted type of peptides of WT1, wherein the cysteine residue is substituted with a defined amino acid residue. The invention includes polynucleotides encoding these peptides and cancer vaccines that utilize them in vivo or in vitro. The peptides comprise an amino acid sequence of the formula: X-Y-Thr-Trp-Asn-Gln-Met-Asn-Leu (SEQ ID NO: 4), where X represents various amino acids, and Y represents either Tyr or Met. These peptides have the activity to induce CTLs, making them valuable in cancer treatment.

Career Highlights

Throughout his career, Naoto Kusunose has worked with notable organizations, including the International Institute of Cancer Immunology and Chugai Pharmaceutical Co., Ltd. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative cancer therapies.

Collaborations

Kusunose has collaborated with esteemed colleagues such as Masashi Gotoh and Haruo Sugiyama. These partnerships have further enriched his research and expanded the impact of his work in the field of cancer immunology.

Conclusion

Naoto Kusunose's contributions to cancer immunology through his patented inventions highlight his role as an innovator in the field. His work continues to pave the way for advancements in cancer treatment and vaccine development.